Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction

被引:33
|
作者
Chan, RKM
Lee, KJ
Calafiore, P
Berlangieri, SU
McKay, WJ
Tonkin, AM
机构
[1] AUSTIN & REPATRIAT MED CTR, DEPT CARDIOL, HEIDELBERG, VIC 3084, AUSTRALIA
[2] AUSTIN & REPATRIAT MED CTR, DEPT NUCL MED, HEIDELBERG, VIC 3084, AUSTRALIA
关键词
D O I
10.1016/0735-1097(96)00069-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of this study was to correlate dobutamine-induced contractile reserve as detected by echocardiography with findings on positron emission tomography in patients with chronic ischemic left ventricular dysfunction, Background. Contractile reserve induced by low dose dobutamine infusion has been proposed as a marker of myocardial viability. Methods. Sixty patients with stable coronary artery disease and left ventricular dysfunction (mean ejection fraction [+/-SD] 29 +/- 10%) underwent transthoracic echocardiography with dobutamine infusion (up to 10 mu g/kg body weight per min) and positron emission tomography with nitrogen-13 ammonia and fluorine-18 (F-18) fluorodeoxyglucose as a perfusion and a metabolic tracer, respectively. Regional wall motion, perfusion and metabolism were analyzed semiquantitatively by using a 16-segment model. Segments with F-18 fluorodeoxyglucose uptake >50% were considered viable on positron emission tomography. Results. After dobutamine infusion, hemodynamic variables changed significantly, and myocardial ischemia was evident in 17 patients, All 60 patients had dysfunctional myocardium considered viable on positron emission tomography (8 +/- 4 segments/patient), whereas 52 patients had dysfunctional myocardium with contractile enhancement by dobutamine echocardiography (4 +/- 2 segments/patient, p = 0.01). The extent of dysfunctional myocardium with contractile reserve appeared to correlate less closely with the total extent of viable dysfunctional myocardium identified by positron emission tomography than with the number of such segments associated with a pattern of perfusion-metabolism mismatch. Conclusions. In patients with chronic ischemic left ventricular dysfunction, echocardiography can be used to identify enhancement in the contractile function of viable dysfunctional myocardium after infusion of low dose dobutamine. In this study, the presence and extent of such enhancement were relatively less than the values obtained from positron emission tomography.
引用
收藏
页码:1601 / 1607
页数:7
相关论文
共 50 条
  • [1] Enoximone echocardiography for identification of viable myocardium in patients with ischaemic ventricular dysfunction: Comparison with dobutamine echocardiography and positron emission tomography
    Carlino, M
    Chierchia, S
    Lu, C
    Margonato, A
    Poletti, R
    Landoni, C
    Lucignani, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 91772 - 91772
  • [2] Dobutamine echocardiography and positron emission tomography for assessing viability in patients with moderate ventricular dysfunction
    FathOrdoubadi, F
    Spyrou, N
    Pagano, D
    Beatt, KJ
    CIRCULATION, 1996, 94 (08) : 3173 - 3173
  • [3] SAFETY OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH CHRONIC ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION
    HEPNER, AM
    BACH, DS
    DEEB, GM
    BOLLING, SF
    BRUNSTING, LA
    SHAYNA, V
    STAFFORD, K
    SCHWAIGER, M
    ARMSTRONG, WF
    CIRCULATION, 1993, 88 (04) : 404 - 404
  • [4] Comparison of enoximone echocardiography, positron emission tomography and dobutamine echocardiography for prediction of recovery of myocardial dysfunction after revascularization
    Lu, C
    Carlino, M
    Landoni, C
    Cappelletti, A
    Maisano, F
    Margonato, A
    Lucignani, G
    Fazio, F
    Chierchia, SL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 257A - 257A
  • [5] Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction
    Yao, SS
    Chaudhry, FA
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2005, 22 (01): : 71 - 83
  • [6] PREDICTION OF VIABLE MYOCARDIUM BY DOBUTAMINE ECHOCARDIOGRAPHY IN PATIENTS WITH CHRONIC LEFT-VENTRICULAR DYSFUNCTION
    SEHGAL, R
    LAMBERT, KL
    SAHAM, GM
    BONOW, RO
    CHAUDHRY, FA
    CLINICAL RESEARCH, 1993, 41 (03): : A683 - A683
  • [7] PREDICTION OF VIABLE MYOCARDIUM BY DOBUTAMINE ECHOCARDIOGRAPHY IN PATIENTS WITH CHRONIC LEFT-VENTRICULAR DYSFUNCTION
    SEHGAL, R
    LAMBERT, KL
    SAHAM, GM
    BERGELSON, BA
    BONOW, RO
    CHAUDHRY, FA
    CLINICAL RESEARCH, 1994, 42 (02): : A160 - A160
  • [8] VALUE OF DOBUTAMINE ECHOCARDIOGRAPHY AND FDC-PET IN EVALUATING PROGNOSIS IN PATIENTS WITH CHRONIC LEFT-VENTRICULAR ISCHEMIC DYSFUNCTION
    PASQUET, A
    GERBER, B
    DHONDT, AM
    DEKOCK, M
    MELIN, JA
    VANOVERSCHELDE, JL
    CIRCULATION, 1995, 92 (08) : 1274 - 1274
  • [9] Limitations of dobutamine echocardiography in patients with significant left ventricular dysfunction
    von Sohsten, R
    Khatiwala, J
    Galatro, K
    Cusick, D
    Amanullah, A
    Chaudhry, FA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 299A - 299A
  • [10] Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
    Williams, MJ
    Odabashian, J
    Lauer, MS
    Thomas, JD
    Marwick, TH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (01) : 132 - 139